Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

OPKO HEALTH, INC.

(OPK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo OPKO Health, Inc.
OPKO Health, Inc. is a healthcare company. Its segments include Diagnostics and Pharmaceutical. The Pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain. The Diagnostics segment consists of the clinical laboratory operations of Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Through Bio-Reference, it operates laboratory divisions, such as Bio-Reference, GenPath (Oncology), GenPath (Women's Health) and GeneDx. Its Pharmaceutical Business have one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Renal Products, Oxyntomodulin, Biologics, Factor VIIa -CTP, hGH-CTP. It also owns an active pharmaceutical ingredients (APIs) manufacturer in Israel through its subsidiary FineTech Pharmaceutical, Ltd.

Number of employees : 5 269 people.
Sales per Business
20192020Delta
Diagnostics716.4379.4%1 278.4889.1% +78.45%
Pharmaceuticals185.5020.6%156.9310.9% -15.4%
USD in Million
Sales per region
20192020Delta
United States751.1083.3%1 317.7791.8% +75.45%
Chile33.643.7%44.153.1% +31.24%
Ireland81.179%43.923.1% -45.89%
Spain18.752.1%16.931.2% -9.68%
Mexico8.030.9%7.870.5% -2.08%
Israel8.771%4.250.3% -51.52%
Other0.480.1%0.530% +10.5%
USD in Million
Managers
Name Title Age Since
Phillip Frost Chairman & Chief Executive Officer 83 2007
Jon Roger Cohen, Dr. Director & Senior Vice President 65 2020
Adam E. Logal CFO, Treasurer, Chief Accounting Officer & SVP 42 2021
Jane H. Hsaio, Dr. Vice Chairman & Chief Technical Officer 72 2007
Steven D. Rubin Director & Executive Vice President-Administration 59 2007
John A. Paganelli Independent Director 85 2003
Richard C. Pfenniger Independent Director 64 2008
Richard Alan Lerner, Dr. Independent Director 81 2007
Lin-Tsing Yu, Dr. Independent Director 76 2009
Richard M. Krasno, Dr. Independent Director 78 2017
Members of the board
Name Title Age Since
Phillip Frost Chairman & Chief Executive Officer 83 2007
John A. Paganelli Independent Director 85 2003
Steven D. Rubin Director & Executive Vice President-Administration 59 2007
Jane H. Hsaio, Dr. Vice Chairman & Chief Technical Officer 72 2007
Richard C. Pfenniger Independent Director 64 2008
Richard Alan Lerner, Dr. Independent Director 81 2007
Lin-Tsing Yu, Dr. Independent Director 76 2009
Richard M. Krasno, Dr. Independent Director 78 2017
Robert S. Fishel, Dr. Independent Director 58 2018
Jon Roger Cohen, Dr. Director & Senior Vice President 65 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 689,817,701 410,582,752 59.5% 8,655,082 1.3% 59.5%
Shareholders
NameEquities%
Phillip Frost 226,367,822 33.2%
The Vanguard Group, Inc. 34,982,775 5.14%
Jane H. Hsaio 29,602,561 4.35%
SSgA Funds Management, Inc. 20,797,208 3.05%
Oracle Investment Management, Inc. 12,819,073 1.88%
BlackRock Fund Advisors 11,787,649 1.73%
Geode Capital Management LLC 7,781,918 1.14%
Orchard Hill Capital Management LP 7,326,900 1.08%
Dimensional Fund Advisors LP 7,232,279 1.06%
Aletheia Research & Management, Inc. 6,726,683 0.99%
Holdings
NameEquities%Valuation
COCRYSTAL PHARMA, INC. (COCP) 2,626,352 2.69% 3,072,832 USD
Company contact information
OPKO Health, Inc.
4400 Biscayne Boulevard
Miami, FL 33137

Phone : +1.305.575.4100
Web : http://www.opko.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of OPKO Health, Inc.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
OPKO HEALTH, INC.-5.82%2 561
JOHNSON & JOHNSON2.49%421 487
ROCHE HOLDING AG15.58%336 383
PFIZER, INC.13.20%233 631
NOVO NORDISK A/S51.58%230 493
ELI LILLY AND COMPANY40.89%214 579
MERCK & CO., INC.-4.24%198 283
ABBVIE INC.2.03%192 463
ASTRAZENECA PLC20.08%186 771
NOVARTIS AG-8.60%185 154
BRISTOL-MYERS SQUIBB COMPANY-5.92%128 216
SANOFI6.90%122 352
AMGEN INC.-9.60%117 421
GLAXOSMITHKLINE PLC4.29%95 969
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-27.49%57 298
BAYER AG-0.56%54 386
JIANGSU HENGRUI MEDICINE CO., LTD.-46.12%50 527
DAIICHI SANKYO COMPANY, LIMITED-16.76%49 253
TAKEDA PHARMACEUTICAL COMPANY LIMITED-13.93%44 698
ASTELLAS PHARMA INC.25.60%31 970